FDA could find itself in danger of losing budget authority if it does not meet the goals in its user fee agreements, threatening a potentially deeper funding cut than the administration already has proposed.
Sen. Richard Burr, R-NC, has floated the idea of adding a provision to the user fee legislation that would dock...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?